Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics Revenue

Anika Therapeutics had revenue of $28.22M in the quarter ending June 30, 2025, a decrease of -8.15%. This brings the company's revenue in the last twelve months to $114.55M, up 16.51% year-over-year. In the year 2024, Anika Therapeutics had annual revenue of $119.91M, down -0.73%.

• Revenue (ttm): $114.55M
• Revenue Growth: +16.51%
• P/S Ratio: 1.13
• Revenue / Employee: $397,736
• Employees: 288
• Market Cap: 128.47M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	119.91M	-885.00K	-0.73%
Dec 31, 2023	120.79M	6.97M	6.12%
Dec 31, 2022	113.83M	-33.97M	-22.98%
Dec 31, 2021	147.79M	17.34M	13.29%
Dec 31, 2020	130.46M	15.85M	13.83%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.